Akari Therapeutics (AKTX) Capital Expenditures (2016)
Akari Therapeutics' (AKTX) quarterly Capital Expenditures came in at $42083.0 in Q1 2016.
Akari Therapeutics (AKTX) Capital Expenditures (2016) Analysis & Trends
Akari Therapeutics has disclosed Capital Expenditures across 1 years of filings, most recently posting $42083.0 for Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 230.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 42,083.00 |
| Mar 31, 2016 | 42,083.00 |